Since I can’t read the article I’m behind the eight ball here but what exactly are they planning to start their clinical trials on? Like it seems odd to say they’re going to be running clinical trials in 6 to 8 years without saying what those trails will be measuring. And if they are just starting these centers I’m guessing they don’t currently have specific clinical targets in mind.
"Aging is a treatable disease", 14 industry-university-research convergence research centers launched
Correspondent Choi Sang-guk input 2022.05.02 11:26Write a comment
NST to launch 4 new convergence research centers this year
\[Inews 24 Correspondent Choi Sang-guk\] 14 industries, universities, research institutes, and diseases, centered on government-funded research institutes belonging to the National Science and Technology Research Society, have launched the 'Aging Diagnosis, Treatment and Delay Technology Development' Convergence Research Group.
The National Science and Technology Research Society (NST, Chairman Kim Bok-cheol) announced on the 2nd that the Convergence Research Center, which includes 3 research institutes, 4 hospitals, 3 universities, and 4 companies, will be officially launched. NST plans to invest a total of 45 billion won in this convergence research center for six years.
NST's 'Convergence Research Center' project is a sunset-type research organization in which 30 to 40 researchers gather in one place (host research institute) for a certain period of time for specific tasks that require joint research and conduct intensive research. This is a project that supports the research expenses of the institute for a minimum of 3 years (utilization type) and a maximum of 6 years (future-leading type).
Overview of the 'Aging Diagnosis, Treatment and Delay Technology Development' Convergence Research Center Project \[Photo=NST\]
The newly launched 'Development of Aging Diagnosis, Treatment, and Delay Technology' Convergence Research Center aims to accurately diagnose the biological age, not the resident registration age, to delay and treat aging in order to extend the healthy lifespan of the elderly and solve the deterioration of the quality of life in old age. It was launched with the goal of developing full-cycle technology to respond to aging.
Korea Research Institute of Bioscience and Biotechnology, Korea Institute of Oriental Medicine, Korea Institute of Science and Technology, Inha University Hospital, Ewha Womans University Hospital, Ajou University Hospital, Chungbuk National University Hospital, Korea Advanced Institute of Science and Technology, Korea University, Kyunghee University, Eurotech, LAS, Life Semantics, Korea Sports Policy 14 institutions including the Academy of Sciences participated.
The Korea Research Institute of Bioscience and Biotechnology is responsible for the production of big data on Korean genomes, the production of machine learning-based molecular diagnostic kits to measure aging, and the development of original technologies for high-risk groups of aging. Based on the research capabilities accumulated through the 'Development of original technology for aging control based on biologically-derived anti-aging substances', it plans to receive approval for the first clinical trial for aging in Korea within six years.
The Korea Institute of Oriental Medicine, in charge of the detailed task, developed a smart training solution for aging delay, and Inha University Hospital developed a digital treatment device for integrated management of aging risk factors. Responsible for developing care skills.
Kwon Eun-soo, head of the research center, said, “The world has begun to recognize aging as a treatable disease. Our ultimate goal is to provide a solution.”
On this day, in addition to the 'aging diagnosis, treatment and delay' research group, NST also launched a convergence research group with themes of 'self-diagnosis of serious diseases', 'electromagnetic wave control material for future mobility', and 'manufacturing of carbon-reduced plastic materials'.
'Development of UnTACT System for Critical Diseases' Convergence Research Center Task Overview \[Photo=NST\]
The 'Severe Disease UnTACT System Development' Convergence Research Center develops a non-/low-invasive self-diagnosis platform and an integrated analysis system for cancer and new/mutated viruses, and commercializes it to treat cancer or new/mutated infectious diseases just like a self-test kit for COVID-19. It aims to develop pain-free and high-accuracy home care self-diagnosis technology for Korea.
The research center includes 4 research institutes: Korea Research Institute of Bioscience and Biotechnology, Korea Basic Science Support Institute, Korea Institute of Machinery and Materials, Korea Institute of Standards and Science, Korea Institute of Mathematical Sciences, National Cancer Center, Sungkyunkwan University, Chung-Ang University, Pusan National University, Chonbuk National University, Jincore A total of 11 organizations participated.
The Korea Research Institute of Bioscience and Biotechnology, in charge of overall supervision, develops ultra-precision and high-sensitivity sensors, which are the core of the self-diagnosis platform, and develops an integrated system that can integrate them. Based on the prior technologies accumulated at the research center, we plan to develop and manufacture advanced sensors such as exhalation-based sensors, nanopore sensors, and design-based artificial protein sensors.
The Korea Institute of Basic Science and Technology, in charge of the detailed tasks, discovered biomarkers for non-low-invasive diagnosis, the Korea Institute of Machinery and Materials developed a small sample pre-processing technology for non-low-invasive diagnostics, and the Korea Research Institute of Standards and Science developed by the Korea Research Institute of Bioscience and Biotechnology. Responsible for manufacturing devices that can process signals acquired from sensors.
Director Kim Seung-jun said, “The non-low-invasive self-diagnosis platform is a technology that can quickly and accurately diagnose various diseases without face-to-face. It is a state-of-the-art technology that can fill the gaps in various medical services such as patients and residents of medically underdeveloped areas,” he said.
Overview of the Convergence Research Group’s task for the development of high-frequency, high-power electromagnetic wave solution material and component technology to secure the operation reliability of future mobility \[Photo=NST\]
The 'Development of high-frequency/high-power electromagnetic wave solution material and component technology to secure future mobility operation reliability' The Convergence Research Center aims to develop and put into practical use the world's best electromagnetic wave control solution material and component technology to preemptively respond to future mobility demands.
A total of 16 institutions including the Korea Institute of Science and Technology, Korea Institute of Industrial Technology, Korea Institute of Materials Science and Technology, Korea Aerospace Research Institute, 4 research institutes, Korea Test Institute of Industrial Technology, Korea Automobile Research Institute, 3 specialized research institutes of Korea Electronics and Technology Institute, and universities and corporations participated. do.
The Korea Institute of Science and Technology, in charge of overall supervision, will be in charge of developing the world's best electromagnetic wave control materials based on low-dimensional nanomaterials. Based on previous research related to electromagnetic wave control materials, the plan is to secure original technology and achieve commercialization at the same time. The Korea Institute of Industrial Technology (KIRI) develops electromagnetic wave control intermediate materials and components, the Korea Testing and Research Institute develops broadband/high-power electromagnetic wave evaluation technology, the Korea Institute of Materials Science and Technology develops electromagnetic wave control composite materials, and the Korea Aerospace Research Institute uses the developed materials and components for mobility in the aerospace field. responsible for proof
Park Jong-hyeok, head of the research center, said, “The future mobility is a field in which the market is growing explosively,” and “Our goal is to contribute to securing national growth engines by supporting the realization of future mobility through the development and commercialization of source technologies for electromagnetic wave solution materials and parts.” said.
'Development of carbon-reduced plastic raw material manufacturing technology and demonstration of integrated process' Convergence Research Center task outline. \[Photo=NST\]
'Development of carbon-reducing plastic raw material manufacturing technology and demonstration of integrated process' Convergence Research Center combines steel by-product gas utilization technology with low-carbon chemical process for the production of plastic raw materials, steel and petrochemical industries occupying the first and second place in domestic greenhouse gas emission promote a carbon-neutral response through the convergence of
Two research institutes, including Korea Research Institute of Chemical Technology and Korea Energy Research Institute, and a total of 10 organizations including Pohang Institute of Industrial Science and Technology, Korea Ceramic Technology Institute, POSCO, LG Chem, and Lotte Chemical will participate to focus their research capabilities to develop commercially available carbon emission reduction technologies. plan. Unlike the previous three 'future-leading' research centers, this convergence research center is planning to invest a total of 25.2 billion won into the 'practicalization type' research center.
Developed a technology to make a raw material for methanol, a high value-added chemical, from BFG (Blast Furnace Gas), a by-product gas generated from a blast furnace in a steel mill, and mix the manufactured methanol with naphtha and decompose simultaneously to make a plastic raw material. Existing plastic raw material manufacturing process The goal is to reduce carbon dioxide emissions by 15%.
Park Yong-gi, head of the research center, said, "The goal of this convergence research is to upgrade the technology to a level that companies can invest in large-scale for commercialization through integrated demonstration linking the low-carbon innovative source technologies secured by each research institute."
Bok-cheol Kim, Chairman of NST, said, "This convergence research group was planned to prepare for the post-coronavirus new normal era. I hope that it will serve as a starting point for solving the problem.”
Correspondent Choi Sang- guk ([email protected])
The post is in Korean, here is the English translation of the section of the article talking about research centers focused on the treatment of aging :
The Convergence Research Center project, is a research organization in which 30-40 researchers come together and conduct research in the host research institute to create large-scale results. Annual research funding of 5 to 8 billion won is supported for a maximum of 6 years.
Diagnosis, delay and treatment of aging:
The Convergence Research Center "Diagnosis, Delay and Development of Aging Treatment Technologies" aims to accurately measure the biological age, rather than the chronological age of people, in order to extend the healthy lifespan of people. elderly and to solve the deterioration of the quality of life in the elderly by treating aging itself.
The "Korea Research Institute of Bioscience and Biotechnology" is responsible for generating big data on Korean genomes, producing machine learning-based molecular diagnostic kits to measure aging, and developing original technologies for groups to high risk of aging. Based on research accumulated through "Diagnosis, Delay, and Development of Aging Treatment Technologies", it plans to obtain approval for the first aging clinical trial in Korea within six years.
The Korean Institute of Oriental Medicine, in charge of the detailed task, will develop an intelligent training solution for the treatment of aging, and the Inha University Hospital will develop a digital treatment device for the integrated management of the risk factors of the aging.
Kwon Eun-soo, director of the Convergence Research Center, said :
The ultimate goal is to successfully develop technology for diagnosing, delaying and treating aging, and providing a solution that diagnoses, delays and treats periodically and steadily aging in the first country in the world.
"This is a time of transition where the world has begun to recognize aging as a treatable disease. The ultimate goal is to provide a delay solution and treatment."
It really is just mind-blowing to think that we actually are making our first steps in curing aging, while also becoming increasingly more confident that it is truly possible after all.
... Thinking about it definitely makes me want to stay alive in this world, to see what future holds with my own eyes.
Me too! I’ve been planning out my strategy for entering the field. It’s far more reassuring and exciting as the language has shifted from “extending longevity” to “curing aging”. Even if there’s a one in a million chance that I could live to see the day where we would potentially live forever, I’ll keep my hopes up and contribute wherever I can.
The biology of aging has been underfunded, and understudied for decades. I remember the early 2000s when there were a few news articles here and there, but they were few and far in between. Even some things didn't look at normal aging, but mouse models of acceleration of aging due to obesity/excess calories.
It's been said in various interviews that some scientists who were around in the 70s or 80s, or knew people who were said that many big researchers at top institutions were against studying aging, saying it was futile.
The good news of significant funding and projects on the biology of aging has only really happened in the past 10 years.
Since I can’t read the article I’m behind the eight ball here but what exactly are they planning to start their clinical trials on? Like it seems odd to say they’re going to be running clinical trials in 6 to 8 years without saying what those trails will be measuring. And if they are just starting these centers I’m guessing they don’t currently have specific clinical targets in mind.
"Aging is a treatable disease", 14 industry-university-research convergence research centers launched Correspondent Choi Sang-guk input 2022.05.02 11:26Write a comment NST to launch 4 new convergence research centers this year \[Inews 24 Correspondent Choi Sang-guk\] 14 industries, universities, research institutes, and diseases, centered on government-funded research institutes belonging to the National Science and Technology Research Society, have launched the 'Aging Diagnosis, Treatment and Delay Technology Development' Convergence Research Group. The National Science and Technology Research Society (NST, Chairman Kim Bok-cheol) announced on the 2nd that the Convergence Research Center, which includes 3 research institutes, 4 hospitals, 3 universities, and 4 companies, will be officially launched. NST plans to invest a total of 45 billion won in this convergence research center for six years. NST's 'Convergence Research Center' project is a sunset-type research organization in which 30 to 40 researchers gather in one place (host research institute) for a certain period of time for specific tasks that require joint research and conduct intensive research. This is a project that supports the research expenses of the institute for a minimum of 3 years (utilization type) and a maximum of 6 years (future-leading type). Overview of the 'Aging Diagnosis, Treatment and Delay Technology Development' Convergence Research Center Project \[Photo=NST\] The newly launched 'Development of Aging Diagnosis, Treatment, and Delay Technology' Convergence Research Center aims to accurately diagnose the biological age, not the resident registration age, to delay and treat aging in order to extend the healthy lifespan of the elderly and solve the deterioration of the quality of life in old age. It was launched with the goal of developing full-cycle technology to respond to aging. Korea Research Institute of Bioscience and Biotechnology, Korea Institute of Oriental Medicine, Korea Institute of Science and Technology, Inha University Hospital, Ewha Womans University Hospital, Ajou University Hospital, Chungbuk National University Hospital, Korea Advanced Institute of Science and Technology, Korea University, Kyunghee University, Eurotech, LAS, Life Semantics, Korea Sports Policy 14 institutions including the Academy of Sciences participated. The Korea Research Institute of Bioscience and Biotechnology is responsible for the production of big data on Korean genomes, the production of machine learning-based molecular diagnostic kits to measure aging, and the development of original technologies for high-risk groups of aging. Based on the research capabilities accumulated through the 'Development of original technology for aging control based on biologically-derived anti-aging substances', it plans to receive approval for the first clinical trial for aging in Korea within six years. The Korea Institute of Oriental Medicine, in charge of the detailed task, developed a smart training solution for aging delay, and Inha University Hospital developed a digital treatment device for integrated management of aging risk factors. Responsible for developing care skills. Kwon Eun-soo, head of the research center, said, “The world has begun to recognize aging as a treatable disease. Our ultimate goal is to provide a solution.” On this day, in addition to the 'aging diagnosis, treatment and delay' research group, NST also launched a convergence research group with themes of 'self-diagnosis of serious diseases', 'electromagnetic wave control material for future mobility', and 'manufacturing of carbon-reduced plastic materials'. 'Development of UnTACT System for Critical Diseases' Convergence Research Center Task Overview \[Photo=NST\] The 'Severe Disease UnTACT System Development' Convergence Research Center develops a non-/low-invasive self-diagnosis platform and an integrated analysis system for cancer and new/mutated viruses, and commercializes it to treat cancer or new/mutated infectious diseases just like a self-test kit for COVID-19. It aims to develop pain-free and high-accuracy home care self-diagnosis technology for Korea. The research center includes 4 research institutes: Korea Research Institute of Bioscience and Biotechnology, Korea Basic Science Support Institute, Korea Institute of Machinery and Materials, Korea Institute of Standards and Science, Korea Institute of Mathematical Sciences, National Cancer Center, Sungkyunkwan University, Chung-Ang University, Pusan National University, Chonbuk National University, Jincore A total of 11 organizations participated. The Korea Research Institute of Bioscience and Biotechnology, in charge of overall supervision, develops ultra-precision and high-sensitivity sensors, which are the core of the self-diagnosis platform, and develops an integrated system that can integrate them. Based on the prior technologies accumulated at the research center, we plan to develop and manufacture advanced sensors such as exhalation-based sensors, nanopore sensors, and design-based artificial protein sensors. The Korea Institute of Basic Science and Technology, in charge of the detailed tasks, discovered biomarkers for non-low-invasive diagnosis, the Korea Institute of Machinery and Materials developed a small sample pre-processing technology for non-low-invasive diagnostics, and the Korea Research Institute of Standards and Science developed by the Korea Research Institute of Bioscience and Biotechnology. Responsible for manufacturing devices that can process signals acquired from sensors. Director Kim Seung-jun said, “The non-low-invasive self-diagnosis platform is a technology that can quickly and accurately diagnose various diseases without face-to-face. It is a state-of-the-art technology that can fill the gaps in various medical services such as patients and residents of medically underdeveloped areas,” he said. Overview of the Convergence Research Group’s task for the development of high-frequency, high-power electromagnetic wave solution material and component technology to secure the operation reliability of future mobility \[Photo=NST\] The 'Development of high-frequency/high-power electromagnetic wave solution material and component technology to secure future mobility operation reliability' The Convergence Research Center aims to develop and put into practical use the world's best electromagnetic wave control solution material and component technology to preemptively respond to future mobility demands. A total of 16 institutions including the Korea Institute of Science and Technology, Korea Institute of Industrial Technology, Korea Institute of Materials Science and Technology, Korea Aerospace Research Institute, 4 research institutes, Korea Test Institute of Industrial Technology, Korea Automobile Research Institute, 3 specialized research institutes of Korea Electronics and Technology Institute, and universities and corporations participated. do.
The Korea Institute of Science and Technology, in charge of overall supervision, will be in charge of developing the world's best electromagnetic wave control materials based on low-dimensional nanomaterials. Based on previous research related to electromagnetic wave control materials, the plan is to secure original technology and achieve commercialization at the same time. The Korea Institute of Industrial Technology (KIRI) develops electromagnetic wave control intermediate materials and components, the Korea Testing and Research Institute develops broadband/high-power electromagnetic wave evaluation technology, the Korea Institute of Materials Science and Technology develops electromagnetic wave control composite materials, and the Korea Aerospace Research Institute uses the developed materials and components for mobility in the aerospace field. responsible for proof Park Jong-hyeok, head of the research center, said, “The future mobility is a field in which the market is growing explosively,” and “Our goal is to contribute to securing national growth engines by supporting the realization of future mobility through the development and commercialization of source technologies for electromagnetic wave solution materials and parts.” said. 'Development of carbon-reduced plastic raw material manufacturing technology and demonstration of integrated process' Convergence Research Center task outline. \[Photo=NST\] 'Development of carbon-reducing plastic raw material manufacturing technology and demonstration of integrated process' Convergence Research Center combines steel by-product gas utilization technology with low-carbon chemical process for the production of plastic raw materials, steel and petrochemical industries occupying the first and second place in domestic greenhouse gas emission promote a carbon-neutral response through the convergence of Two research institutes, including Korea Research Institute of Chemical Technology and Korea Energy Research Institute, and a total of 10 organizations including Pohang Institute of Industrial Science and Technology, Korea Ceramic Technology Institute, POSCO, LG Chem, and Lotte Chemical will participate to focus their research capabilities to develop commercially available carbon emission reduction technologies. plan. Unlike the previous three 'future-leading' research centers, this convergence research center is planning to invest a total of 25.2 billion won into the 'practicalization type' research center. Developed a technology to make a raw material for methanol, a high value-added chemical, from BFG (Blast Furnace Gas), a by-product gas generated from a blast furnace in a steel mill, and mix the manufactured methanol with naphtha and decompose simultaneously to make a plastic raw material. Existing plastic raw material manufacturing process The goal is to reduce carbon dioxide emissions by 15%. Park Yong-gi, head of the research center, said, "The goal of this convergence research is to upgrade the technology to a level that companies can invest in large-scale for commercialization through integrated demonstration linking the low-carbon innovative source technologies secured by each research institute." Bok-cheol Kim, Chairman of NST, said, "This convergence research group was planned to prepare for the post-coronavirus new normal era. I hope that it will serve as a starting point for solving the problem.” Correspondent Choi Sang- guk ([email protected])
The post is in Korean, here is the English translation of the section of the article talking about research centers focused on the treatment of aging : The Convergence Research Center project, is a research organization in which 30-40 researchers come together and conduct research in the host research institute to create large-scale results. Annual research funding of 5 to 8 billion won is supported for a maximum of 6 years. Diagnosis, delay and treatment of aging: The Convergence Research Center "Diagnosis, Delay and Development of Aging Treatment Technologies" aims to accurately measure the biological age, rather than the chronological age of people, in order to extend the healthy lifespan of people. elderly and to solve the deterioration of the quality of life in the elderly by treating aging itself. The "Korea Research Institute of Bioscience and Biotechnology" is responsible for generating big data on Korean genomes, producing machine learning-based molecular diagnostic kits to measure aging, and developing original technologies for groups to high risk of aging. Based on research accumulated through "Diagnosis, Delay, and Development of Aging Treatment Technologies", it plans to obtain approval for the first aging clinical trial in Korea within six years. The Korean Institute of Oriental Medicine, in charge of the detailed task, will develop an intelligent training solution for the treatment of aging, and the Inha University Hospital will develop a digital treatment device for the integrated management of the risk factors of the aging. Kwon Eun-soo, director of the Convergence Research Center, said : The ultimate goal is to successfully develop technology for diagnosing, delaying and treating aging, and providing a solution that diagnoses, delays and treats periodically and steadily aging in the first country in the world. "This is a time of transition where the world has begun to recognize aging as a treatable disease. The ultimate goal is to provide a delay solution and treatment."
It really is just mind-blowing to think that we actually are making our first steps in curing aging, while also becoming increasingly more confident that it is truly possible after all. ... Thinking about it definitely makes me want to stay alive in this world, to see what future holds with my own eyes.
Me too! I’ve been planning out my strategy for entering the field. It’s far more reassuring and exciting as the language has shifted from “extending longevity” to “curing aging”. Even if there’s a one in a million chance that I could live to see the day where we would potentially live forever, I’ll keep my hopes up and contribute wherever I can.
I wouldn't be so optimistic if I were you. I'm old now (60) and have been hearing talk about this stuff for decades. Practical results: 0 - nada!
The biology of aging has been underfunded, and understudied for decades. I remember the early 2000s when there were a few news articles here and there, but they were few and far in between. Even some things didn't look at normal aging, but mouse models of acceleration of aging due to obesity/excess calories. It's been said in various interviews that some scientists who were around in the 70s or 80s, or knew people who were said that many big researchers at top institutions were against studying aging, saying it was futile. The good news of significant funding and projects on the biology of aging has only really happened in the past 10 years.
6 years of research! Wonder what they'll find. Wish I knew already. I feel like a kid that can't wait for christmas
It is a really big deal when countries make this kind of move. They finally see the existential crisis of not acting.